期刊文献+

健脾解毒汤联合阿维A治疗斑块状银屑病80例 被引量:2

Jianpi Jiedu Tang Combined with Avermectin A for Training Plaque Psoriasis: A Report of 80 Cases
下载PDF
导出
摘要 目的:探讨健脾解毒汤联合阿维A胶囊治疗斑块状银屑病的临床效果及安全性分析。方法:将斑块状银屑病患者160例采用随机数表法分为两组,每组各80例,对照组给予阿维A胶囊口服,治疗组在对照组的基础上给予健脾解毒汤。疗程均为8周,观察两组患者临床疗效。结果:治疗组有效率显著高于对照组,两组比较差异有统计学意义(P<0.05);治疗后治疗组PASI评分和DLQI评分均优于对照组(P<0.05);对照组不良反应高于治疗组(P<0.05)。结论:健脾解毒汤联合阿维A治疗斑块状银屑病效果显著,可有效改善患者临床症状及生活质量,值得在临床上推广使用。 Objective: To investigate the clinical effect and safety of Jianpi Jiedu Tang combined with avermectin A capsule in the treatment of plaque psoriasis. Methods: 160 patients were divided into two groups,each group had 80 cases,control group was given avermectin A capsule; the treatment group was given Jianpi Jiedu Tang based on the basis of the control group. The two groups were treated for 8 weeks,the clinical efficacy of the two groups were observed. Results: After the treatment,the effective rate of the control group was lower than that of treatment group(P〈0. 05); PASI score and DLQI score of the treatment group were better than those of the control group(P〈0. 05); the incidence of adverse reaction in the control group was higher than treatment group(P〈0. 05). Conclusion: Jianpi Jiedu Tang combined with avermectin A for treating plaque psoriasis is effect,clinical symptom and quality of life of patients can be improved,it is used in clinical practice.
作者 吴咏梅 李强
出处 《辽宁中医杂志》 CAS 北大核心 2015年第3期547-548,共2页 Liaoning Journal of Traditional Chinese Medicine
关键词 健脾解毒汤 阿维A胶囊 斑块状银屑病 Jianpi Jiedu Tang avermectin A capsules plaque psoriasis
  • 相关文献

参考文献6

二级参考文献23

  • 1冯素英,林麟,靳培英.维A酸类药的临床应用、不良反应及对策[J].中华皮肤科杂志,2003,36(7):418-420. 被引量:31
  • 2刘红霞,刘朝霞,张成会.调理脾肾法治疗银屑病的探讨[J].新疆中医药,2006,24(2):61-62. 被引量:16
  • 3杨光艳,周飞红,江平.阿维A联合中药治疗银屑病28例[J].国际皮肤性病学杂志,2006,32(3):197-197. 被引量:3
  • 4周密妹,姚伟星.银屑病发病机理及药物治疗进展[J].抗感染药学,2006,3(3):97-101. 被引量:9
  • 5邓丙戍,张志礼.银屑病[M].北京:科学技术文献出版社,2003.188.
  • 6赵辩.临床皮肤病学[M].3版.南京:江苏科学技术出版社,2001:759-772
  • 7Krueger G,Koo J,Lebwohl M,et al.The impact of psoriasis on quality of lifer results of a 1998 National Psoriasis Foundation patient-membership survey[J].Arch Dermatol,2001,137(3):280-284.
  • 8Mazzotti E,Picardi A,Sampogna F,et al.Sensitivity of the Dermatology Life Quality Index to clinical change in patients with psoriasis[J].Br J Dermatol,2003,149(2):318-322.
  • 9Zaghloul SS,Goodfield MJ.Objective assessment of compliance with psoriasis treatment[J].Arch Dermatol,2004,140(4):408-414.
  • 10Feldman SR,Menter A,Koo JY.Improved health-related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis[J].Br J Dermatol,2004,150(2):317-326.

共引文献63

同被引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部